DJIA 17,683.58 -46.53 -0.26%
NASDAQ 4,991.94 0.00 0.00%
S&P 500 2,068.76 -8.02 -0.39%
market minute promo

GlaxoSmithKline (NYSE: GSK)

41.95 -0.31 (-0.73%)

REAL-TIME: Last trade at

Extended Hours: $41.65 -$0.30 (-0.72%)
Quote as of (NYSE)

company name or ticker

Recent Quotes

GSK $41.95 -0.73%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $41.94
Previous Close $42.26
Daily Range $41.78 - $42.17
52-Week Range $41.25 - $54.78
Market Cap $101.3B
P/E Ratio 14.52
Dividend (Yield) $2.31 (6.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,051,599
Average Daily Volume 3,925,062
Current FY EPS $2.45




Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary Rss Feed

This Could Be Johnson & Johnson’s Future

As competition heats up for Johnson & Johnson's current blockbuster drugs like Zytiga and Remicade, we have to look into the pipeline to see what the future could hold.

Adaptimmune's IND Application for MAGE-A10 Accepted - Analyst Blog

Premarket Biotech Digest: Arrowhead Initiates Dosing, Vertex Orkambi Approval, Insider Sales

Week In Review: Zhongheng Pays $52 Million For Oramed's Diabetes Drugs

GlaxoSmithKline: An Undervalued 'Work In Progress'

Sector's Smaller Players Show The Way

PSA: Afrezza Is NOT Exubera

Premarket Biotech Digest: Gilead Files TAF NDA, Pristiq Goes Generic, Biocept Surges 7%

Premarket Biotech Digest: Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit

Best 3 Yielding Buy-Rated Stocks: VLY, LHO, GSK

See More GSK News...

GSK's Top Competitors

GSK $41.95 (-0.73%)
Current stock: GSK
JNJ $98.20 (-0.24%)
Current stock: JNJ
NVS $98.62 (-1.18%)
Current stock: NVS
RHHBY $35.09 (-0.23%)
Current stock: RHHBY